Back
Capricor Therapeutics Stock Price Chart
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Buy
59
CAPR
Capricor Therapeutics
Last Price:
18.47
Seasonality Move:
15.69%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- The current trend is relatively stagnant and CAPR is experiencing selling pressure, which indicates risk of future bearish movement.
Capricor Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.54 | Sell |
| 20-day SMA: | 19.86 | Sell |
| 50-day SMA: | 14.35 | Buy |
| 200-day SMA: | 7.37 | Buy |
| 8-day EMA: | 18.62 | Sell |
| 20-day EMA: | 18.7 | Sell |
| 50-day EMA: | 15.43 | Buy |
| 200-day EMA: | 8.86 | Buy |
Capricor Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.75 | Buy |
| Relative Strength Index (14 RSI): | 44.59 | Sell |
| Chaikin Money Flow: | -1422516 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.09 - 21.15) | Sell |
| Bollinger Bands (100): | (2.49 - 16.27) | Buy |
Capricor Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Capricor Therapeutics Stock
Is Capricor Therapeutics Stock a Buy?
- Capricor Therapeutics share price is 16.91 while CAPR 8-day simple moving average is 18.54, which is a Sell signal.
- The stock price of CAPR is 16.91 while Capricor Therapeutics 20-day SMA is 19.86, which makes it a Sell.
- Capricor Therapeutics 50-day simple moving average is 14.35 while CAPR share price is 16.91, making it a Buy technically.
- CAPR stock price is 16.91 and Capricor Therapeutics 200-day simple moving average is 7.37, creating a Buy signal.
CAPR Technical Analysis vs Fundamental Analysis
Buy
59
Capricor Therapeutics (CAPR)
is a Buy
Is Capricor Therapeutics a Buy or a Sell?
-
Capricor Therapeutics stock is rated a Buy
The current Capricor Therapeutics [CAPR] share price is $16.91. The Score for CAPR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Capricor Therapeutics Stock Info
Market Cap:
550.23M
Price in USD:
16.91
Share Volume:
1.68M
Capricor Therapeutics 52-Week Range
52-Week High:
23.40
52-Week Low:
2.80
Buy
59
Capricor Therapeutics (CAPR)
is a Buy
Capricor Therapeutics Share Price Forecast
-
What is the Capricor Therapeutics stock price today?
The Capricor Therapeutics stock price is 16.91 USD today. -
Will CAPR stock go up or go down?
Capricor Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Capricor Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Capricor Therapeutics is not overvalued.
Is Capricor Therapeutics Stock a Buy?
- Capricor Therapeutics share price is 16.91 while CAPR 8-day exponential moving average is 18.62, which is a Sell signal.
- The stock price of CAPR is 16.91 while Capricor Therapeutics 20-day EMA is 18.70, which makes it a Sell.
- Capricor Therapeutics 50-day exponential moving average is 15.43 while CAPR share price is 16.91, making it a Buy technically.
- CAPR stock price is 16.91 and Capricor Therapeutics 200-day simple moving average is 8.86, creating a Buy signal.
Fundamental Analysis of Capricor Therapeutics
Is Capricor Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.49 per share.
Technical Analysis of Capricor Therapeutics
Should I short Capricor Therapeutics stock?
- CAPR Moving Average Covergence Divergence (MACD) indicator is 0.75, suggesting Capricor Therapeutics is a Buy
- Capricor Therapeutics Relative Strength Index (RSI) is 44.59, which suggest Capricor Therapeutics is oversold
- The Bollinger Bands (25) for Capricor Therapeutics is (18.09 - 21.15), which suggest Capricor Therapeutics is a Buy
- The Bollinger Bands (100) for Capricor Therapeutics is (2.49 - 16.27), which suggest Capricor Therapeutics is a Buy
* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.